Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial

INTRODUCTION: Aromatase inhibitors are effective in lowering breast cancer incidence among postmenopausal women, but adverse events represent a barrier to their acceptability and adherence as a preventive treatment. This study aims to assess whether lowering exemestane schedule may retain biological...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrieri-Gonzaga, Aliana, Serrano, Davide, Thomas, Parjhitham, Crew, Katherine D., Kumar, Nagi B., Gandini, Sara, Vornik, Lana A., Lee, Jack, Cagnacci, Sara, Vicini, Elisa, Accornero, Chiara A., D'Amico, Mauro, Guasone, Flavio, Spinaci, Stefano, Webber, Tania B., Brown, Powel H., Szabo, Eva, Heckman-Stoddard, Brandy, Bonanni, Bernardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429140/
https://www.ncbi.nlm.nih.gov/pubmed/34216815
http://dx.doi.org/10.1016/j.cct.2021.106498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429140/
https://www.ncbi.nlm.nih.gov/pubmed/34216815
http://dx.doi.org/10.1016/j.cct.2021.106498

Ejemplares similares